Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
Detection Principle
ImmunoAssay-Antibody
Target
IgG
Testing Method Category
Other Immuno assay
Testing Method
LIAISON SARS-CoV-2 from DiaSorin
Testing Method - Additional Info
A retrospective validation study was conducted including the serum of 125 patients in order to determine the analytical and clinical performances of the LIAISON®SARS-CoV-2 from DiaSorin® detecting anti-SARS-CoV-2 IgG and to compare its clinical performance with the enzyme-linked immunosorbent assay (ELISA) test from Euroimmun®
Reported Performance
sensitivity: 100%; specificity: 99% compared to RTq PCR; sensitivity: 100%; specificity: 96% compared to ELISA
Sample Size
125 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements